{"slideshow_credits": null, "snippet": "Eric T. Schneiderman has begun an inquiry into whether Turing Pharmaceuticals violated antitrust rules by restricting distribution of a drug, Daraprim, as a way to thwart generic competition.", "abstract": "New York State Atty Gen Eric T Schneiderman starts investigation into Turing Pharmaceuticals, which skyrocketed price of infection drug, causing backlash against high pharmaceutical prices; Schneiderman's office has addressed letter of inquiry directly to Turing head Martin Shkreli. ", "section_name": "Business Day", "print_page": "4", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/10/13/business/new-york-attorney-general-examining-if-turing-restricted-drug-access.html", "lead_paragraph": "Eric T. Schneiderman has begun an inquiry into whether Turing Pharmaceuticals violated antitrust rules by restricting distribution of a drug, Daraprim, as a way to thwart generic competition.", "headline": {"main": "New York Attorney General Examining Whether Turing Restricted Drug Access", "print_headline": "New York Attorney General Examining if Turing Restricted Drug Access"}, "_id": "561c538238f0d84d2f3b8ac8", "word_count": "785", "multimedia": [{"height": 126, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "legacy": {"thumbnail": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-10-13T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "glocations", "value": "New York State", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Schneiderman, Eric T", "is_major": "Y", "rank": "4"}, {"name": "persons", "value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "5"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}